Cargando…

Remote Prescription During Pandemic: Challenges and Solutions

The current COVID-19 pandemic has created an awareness and at the same time provides an impetus to transform digitalisation of healthcare delivery. Remote prescription is one key component of telemedicine, but it is the easiest and already practised in most places during the current pandemic even wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Ee-Chien, Chen, Celeste Yan-Teng, Tan, Eng-King
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. on behalf of IMSS. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825817/
https://www.ncbi.nlm.nih.gov/pubmed/33500154
http://dx.doi.org/10.1016/j.arcmed.2020.12.007
_version_ 1783640396506595328
author Lim, Ee-Chien
Chen, Celeste Yan-Teng
Tan, Eng-King
author_facet Lim, Ee-Chien
Chen, Celeste Yan-Teng
Tan, Eng-King
author_sort Lim, Ee-Chien
collection PubMed
description The current COVID-19 pandemic has created an awareness and at the same time provides an impetus to transform digitalisation of healthcare delivery. Remote prescription is one key component of telemedicine, but it is the easiest and already practised in most places during the current pandemic even without the framework of virtual medicine in place. However, remote prescription, with its antecedent problems cannot be properly and safely executed in isolation. To ensure patients' safety and health outcomes, specific guidelines will need to be developed to cater for specific medical conditions to address individual drug prescriptions and concerns. There is a need for a robust governance to ensure that patient's safety is the foremost priority, and provisions should be made for requirements of remote prescription in the different medical subspecialities. The pandemic provides an enormous opportunity for stakeholders and policymakers to come together to create a seamless and user friendly and yet innovative healthcare ecosystem to transform clinical healthcare delivery with patient safety as the core driver in the implementation.
format Online
Article
Text
id pubmed-7825817
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier Inc. on behalf of IMSS.
record_format MEDLINE/PubMed
spelling pubmed-78258172021-01-25 Remote Prescription During Pandemic: Challenges and Solutions Lim, Ee-Chien Chen, Celeste Yan-Teng Tan, Eng-King Arch Med Res Opinion The current COVID-19 pandemic has created an awareness and at the same time provides an impetus to transform digitalisation of healthcare delivery. Remote prescription is one key component of telemedicine, but it is the easiest and already practised in most places during the current pandemic even without the framework of virtual medicine in place. However, remote prescription, with its antecedent problems cannot be properly and safely executed in isolation. To ensure patients' safety and health outcomes, specific guidelines will need to be developed to cater for specific medical conditions to address individual drug prescriptions and concerns. There is a need for a robust governance to ensure that patient's safety is the foremost priority, and provisions should be made for requirements of remote prescription in the different medical subspecialities. The pandemic provides an enormous opportunity for stakeholders and policymakers to come together to create a seamless and user friendly and yet innovative healthcare ecosystem to transform clinical healthcare delivery with patient safety as the core driver in the implementation. Published by Elsevier Inc. on behalf of IMSS. 2021-05 2021-01-23 /pmc/articles/PMC7825817/ /pubmed/33500154 http://dx.doi.org/10.1016/j.arcmed.2020.12.007 Text en © 2021 Published by Elsevier Inc. on behalf of IMSS. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Opinion
Lim, Ee-Chien
Chen, Celeste Yan-Teng
Tan, Eng-King
Remote Prescription During Pandemic: Challenges and Solutions
title Remote Prescription During Pandemic: Challenges and Solutions
title_full Remote Prescription During Pandemic: Challenges and Solutions
title_fullStr Remote Prescription During Pandemic: Challenges and Solutions
title_full_unstemmed Remote Prescription During Pandemic: Challenges and Solutions
title_short Remote Prescription During Pandemic: Challenges and Solutions
title_sort remote prescription during pandemic: challenges and solutions
topic Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825817/
https://www.ncbi.nlm.nih.gov/pubmed/33500154
http://dx.doi.org/10.1016/j.arcmed.2020.12.007
work_keys_str_mv AT limeechien remoteprescriptionduringpandemicchallengesandsolutions
AT chencelesteyanteng remoteprescriptionduringpandemicchallengesandsolutions
AT tanengking remoteprescriptionduringpandemicchallengesandsolutions